CMPS: COMPASS Pathways plc
Performance
CMPS +68.44%
Watchlist
Select an item
Summary
CMPS at a glance
CMPS returned +68.44% over the past year and -28.39% a year over five years. Its worst drop in that year was -48.58%, smaller than 25% of stocks on Redstone, and its Sharpe ratio of 0.96 beats 73% of stocks on Redstone. It pays no dividends.
Current Drawdown
-39.57%
Rolling Volatility
121.49%
Actions
Metrics
Risk Indicators
Alpha71.38%
Beta1.86x
Sharpe0.96
Sortino1.72
Omega1.20
Calmar1.41
Martin5.09
Profile
About CMPS
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.3B
- Listed
- Sep 2020
- Employees
- 156
- Headquarters
- Chesire, X0
- Website
- compasspathways.com
Comparisons